Low Prevalence of Mumps IgG Antibodies among the Paediatric Population Attending Tertiary Care Hospital in Southern India- A Pilot Study
Dear Editor, Mumps is a Vaccine-Preventable Disease (VPD) that can cause self-limiting parotid glands swelling to complicated meningitis, deafness, and infertility. In India, Mumps vaccine is not included in the universal immunisation program; hence sporadic outbreaks and incidents have occurred ar...
Main Authors: | Aridass Dhanasezhian, Murugesan Amudhan, G Sucila Thangam |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2023-06-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/18047/64075_CE[Ra1]_F(IS)_PF1(AS_SHU)_PN(KM).pdf |
Similar Items
-
Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
by: Dong Li, et al.
Published: (2022-11-01) -
Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina
by: Carla Vizzotti, et al.
Published: (2023-03-01) -
Two-year antibody persistence in children vaccinated at 12–15 months with a measles-mumps-rubella virus vaccine without human serum albumin
by: Andrea A. Berry, et al.
Published: (2017-07-01) -
Seroprevalence for Measles, Varicella, Mumps and Rubella in the Trainee Obstetric Population: A Survey in Southern Italy
by: Brunella Perfetto, et al.
Published: (2024-03-01) -
Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study
by: The MMR-162 Study Group
Published: (2018-12-01)